CytomX Therapeutics (CTMX) Profit Margin (2014 - 2026)
CytomX Therapeutics (CTMX) profit margin from Sep 30, 2014 to Mar 31, 2026. The current CytomX Therapeutics (CTMX) profit margin is -177.88%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of CytomX Therapeutics (CTMX)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -22.80% | -198.78% |
| 2024 | 23.08% | -4197.67% |
| 2023 | -0.56% | -99.70% |
| 2022 | -186.83% | -39.84% |
| 2021 | -310.56% | -0.73% |
| 2021 | -312.85% | -7.20% |
| 2021 | -337.11% | +10.94% |
| 2021 | -303.86% | +6.80% |
| 2021 | -284.51% | +768.42% |
| 2020 | -32.76% | -65.41% |
| 2020 | -94.72% | -71.73% |
| 2020 | -335.07% | -7.42% |
| 2020 | -361.95% | -1884.99% |
| 2020 | 20.28% | -104.74% |
| 2019 | -428.14% | -13.29% |
| 2019 | -493.75% | +247.26% |
| 2018 | -142.18% | -24.08% |
| 2018 | -187.29% | +197.16% |
| 2018 | -63.03% | -42.30% |
| 2018 | -109.24% | +81.52% |
| 2017 | -60.18% | +41.73% |
| 2017 | -42.46% | -85.27% |
| 2017 | -288.23% | +306.52% |
| 2017 | -70.90% | -84.53% |
| 2016 | -458.37% | +7.87% |
| 2016 | -424.93% | -7.40% |
| 2016 | -458.90% | -36.45% |
| 2016 | -722.07% | +57.40% |
| 2015 | -458.75% | -25.02% |
| 2015 | -611.86% | +114.83% |
| 2015 | -284.80% | -20.20% |
| 2015 | -356.90% | -40.18% |
| 2014 | -596.65% | +219.10% |
| 2014 | -186.98% | -74.59% |
| 2014 | -735.82% | -72.30% |
| 2014 | -2656.25% | +56.15% |
| 2013 | -1701.12% | N/A |
Comparison CytomX Therapeutics (CTMX) profit margin with competitors
CytomX Therapeutics (CTMX) profit margin is -177.88%.